MEC Plus Full List View

MEC Plus

Small Cell Lung Cancer
Small Cell Lung Cancer
Edgardo S. Santos Castillero, MD, FACP, FASCO
Neoadjuvant and Adjuvant Immunotherapy
Neoadjuvant and Adjuvant Immunotherapy
Luis E. Raez, MD, FACP, FCCP
Immunotherapy in HCC
Immunotherapy in HCC
Rachna T. Shroff, MD, MS, FASCO
Payor Benefits Design Changing Oncology Care Delivery
Payor Benefits Design Changing Oncology Care Delivery
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Recent Advances in Breast Cancer
Recent Advances in Breast Cancer
Mili Arora, MD
Recent Advances in Radiation Treatment for Early-Stage Breast Cancer
Recent Advances in Radiation Treatment for Early-Stage Breast Cancer
Lori Pierce, MD
State of the Art in Genitourinary Cancers
State of the Art in Genitourinary Cancers
Nicholas Mitsiades, MD, PhD
New Therapeutic Directions in Lung Cancer
New Therapeutic Directions in Lung Cancer
Jonathan W. Riess, MD, MS
Updates in Gastrointestinal Cancers
Updates in Gastrointestinal Cancers
Richard Bold, MD, MBA
Updates in Lymphomas
Updates in Lymphomas
Joseph Tuscano, MD
Updates in CAR-T Therapies
Updates in CAR-T Therapies
Naseem Esteghamat, MD, MS
Updates in the Surgical Management of Head and Neck Cancers
Updates in the Surgical Management of Head and Neck Cancers
Andrew Birkeland, MD
New Advances in the Medical Management of Head and Neck Cancers
New Advances in the Medical Management of Head and Neck Cancers
Siao-Yi Wang, MD
Updates in Prostate Cancer: Combination Therapy Becoming the Best Approach?
Updates in Prostate Cancer: Combination Therapy Becoming the Best Approach?
Chandler Park, MD, FACP
Updates in Colorectal Cancer
Updates in Colorectal Cancer
Fernando de Zarraga, MD
Updates in Cholangiocarcinoma and Pancreas Cancer: What is new in Targeted Therapy or Immunotherapy?
Updates in Cholangiocarcinoma and Pancreas Cancer: What is new in Targeted Therapy or Immunotherapy?
Milind M. Javle, MD
Updates in Kidney and Bladder Cancers: Where we are with Immunotherapy and Precision Medicine?
Updates in Kidney and Bladder Cancers: Where we are with Immunotherapy and Precision Medicine?
Karine Tawagi, MD
Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations
Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations
Ritu Salani, MD, MBA
Developments in Head and Neck Cancers Including Thyroid Malignancies
Developments in Head and Neck Cancers Including Thyroid Malignancies
Moises Harari-Turquie, MD
Novel Frontiers in the Use of ctDNA in Oncology
Novel Frontiers in the Use of ctDNA in Oncology
Christian Rolfo, MD, PhD, MBA, Dr.hc.